期刊文献+

限制性红细胞输血策略的依据及输血阈值 被引量:5

下载PDF
导出
摘要 从世界范围看,由于广泛存在对血液的不正确使用,造成临床血液供应紧缺,且增加患者的健康风险,为此,WHO血液安全和临床技术策略指出:提高临床输血水平,避免不必要的输血是保证输血安全的一项重要措施。临床治疗贫血的传统输血阈值是Hb100g/L(Hct 30%),该值是根据最大氧输送到外周器官的理论计算值而人为设定的。
作者 岑宪铭
出处 《临床输血与检验》 CAS 2016年第1期90-94,共5页 Journal of Clinical Transfusion and Laboratory Medicine
  • 相关文献

参考文献37

  • 1WHO.Blood safety and clinical technology strategy 2000-2003[J]. Geneva, 2001,2-3.
  • 2Linden PV.Anemia in critically ill patients:How much can they tolerate? [J]Transfusion Alternative in Transfusion Medicine,2008,4(4): 121-128.
  • 3H6bert PC,WellS G,Blajchman MA,et al.A mul ticenter,ranodomized,controlled clinical trial oftransfusion requirements in critical care[J].N Engl J Med, 1999,340(6):409-417.
  • 4Lacroix J,H6bert PC,Hutchison JS,et al.Transfusion strategies for patients in pediatric intensive care units[J].The N Engl J Med,2007.356(16):1609-1619.
  • 5Grover M,Talwalkar MS,Casbard A,et al. Silent myocardial ischaemia and haemoglobin concentration:a randomized controlled trial of transfusion strategy in lower limb arthroplasty[J].Vox Sanguinis,2006,90(2): 105-112.
  • 6Hajjar LA,Vincent JL,Galas FR,et al.Transfusion requirements after cardiac surgery:the TRACS randomized controlled trial[J]. JMMA,2010,304(14): 1559-1567.
  • 7Carson JL,Terrin ML, Noveck H,et al.Liberal or restrictive transfusion in high-risk patients after hip surgery[J]. N Engl J Med,2011,365(26):2453-2462.
  • 8Vuille-Lessard ,Boudreault D,Girard F,et al.Postoperative anemia dose not impede functional outcome and quality of life early after hip and knee arthroplasties[J].Transfusion,2012,52(2):261-270.
  • 9Shehata N,Burns LA,Nathan H,et al.A randomized controlled pilot study of adherence to transfusion strategies in cardiac surgery[J]. Transfusion,2012,52( 1):91-99.
  • 10Cooper HA,Rao SV,Greenberg MD,et al.Conservative versus liberal red cell transfusion in acute myocardial infarction(the CRIT randomized Pilot Study) [J].Am J Cardiol,2011,108(8): 1108-1111.

二级参考文献73

  • 1邓硕曾,宋海波,刘进.循证输血与输血指南[J].中国输血杂志,2006,19(4):263-264. 被引量:72
  • 2卫生部.临床输血技术规范.卫医发[2000]84号.
  • 3American society of anesthesiologists task force on perioperativeblood transfusion and adjuvant therapies.practice guidelines forperioperative blood transfusion and adjuvant therapies:an updatedreport by the american society of anesthesiologists task force onperioperative blood transfusion and adjuvant therapies.Anesthesiol-ogy,2006,105(1):198-208.
  • 4Hahn RG.Estimating allowable blood loss with correction for varia-tions in blood volume.Acta Anaesthesiol Scand,1989,33(6):508-12.
  • 5Guyatt GH,Cook DJ,Jaeschke R,et al.Grades of recommendation for antithrombotic agents:American college of chest physicians evi-dence-based clinical practice guidelines(8th ed).Chest,2008,133(6Suppl):123S-131S.
  • 6Cardone D,Klein AA.Perioperative blood conservation.Eur J An-aesthesiol,2009,26(9):722-729.
  • 7Hernigou P,Beaujean F.Treatment of osteonecrosis with autologous bone marrow grafting.Clin Orthop Relat Res,2002(405):14-23.
  • 8Goodnough LT,Brecher ME,Kanter MH,et al.Transfusion medicine.Part 1:Blood transfusion[J].N Engl J Med 1999;340(6):438
  • 9Goodnough,LT.Pharmacologic alternatives to blood[A].In:Duguid J,Goodnough LT,Desmond MJ ed.Transfusion medicine in practice[M].10rd ed.London:Martin Dunitz Ltd,2002,199-213
  • 10Hutchinson AB,Ferguson D,Graham ID,et al.Utilization of technologies to reduce allogeneic blood transfusion in the United States[J].Transfusion Med,2001,11(2):79

共引文献91

同被引文献32

引证文献5

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部